Skip to main content
SpringerLink
Log in
Book cover

Obstetric and Gynecologic Nephrology pp 129–145Cite as

Endocrine Considerations in Pregnant Women with Chronic Kidney Disease

  • Chapter
  • First Online:

  • 683 Accesses

Abstract

Women with advanced chronic kidney disease (CKD) may have impaired fertility making conception difficult. In addition, in these women, pregnancy is high risk and associated with increased complications. This is further complicated by having an endocrinopathy such as thyroid disease or diabetes. As a result, a multidisciplinary team consisting of an endocrinologist, nephrologist, obstetrician, or maternal-fetal-medicine physician is warranted. Management requires consideration of hormonal levels and non-teratogenic medications.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Palmer BF, Clegg DJ. Gonadal dysfunction in chronic kidney disease. Rev Endocr Metab Disord [Internet]. 2016 [cited 2017 Jan 23]. Available from: https://doi.org/10.1007/s11154-016-9385-9

    Article  CAS  Google Scholar 

  2. Palmer B. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther. 2003;10(1):48–60.

    Article  PubMed  Google Scholar 

  3. Adamczak M, Więcek A. Endocrine disorders in chronic kidney disease. Arici M. Management of chronic kidney disease [Internet]. Berlin: Springer Berlin Heidelberg; 2014 [cited 2016 Dec 30], p. 267–78. Available from: https://doi.org/10.1007/978-3-642-54637-2_19.

    Google Scholar 

  4. Holley JL. The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis. 2004;11(4):337–41.

    Article  PubMed  Google Scholar 

  5. Sikora-Grabka E, Adamczak M, Kuczera P, Szotowska M, Madej P, Wiecek A. Serum anti-Müllerian hormone concentration in young women with chronic kidney disease on hemodialysis, and after successful kidney transplantation. Kidney Blood Press Res. 2016;41(5):552–60.

    Article  CAS  PubMed  Google Scholar 

  6. Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol. 1999;10(6):1381–8.

    CAS  PubMed  Google Scholar 

  7. Basok EK, Atsu N, Rifaioglu MM, Kantarci G, Yildirim A, Tokuc R. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol. 2009;41(3):473–81.

    Article  PubMed  Google Scholar 

  8. Castillo AA, Lew SQ, Smith AM, Bosch JP. Women issues in female patients receiving peritoneal dialysis. Adv Ren Replace Ther. 1999;6(4):327–34.

    Article  CAS  PubMed  Google Scholar 

  9. Gardner D, Shoback D. Greenspan’s basic & clinical endocrinology. 8th ed. New York: McGraw Hill; 2007. p. 662–743.

    Google Scholar 

  10. Young W. The Netter collection of medical illustrations. 2nd ed. Philadelphia: Elsevier Saunders; 2011. p. 131–51.

    Google Scholar 

  11. Molina P. Endocrine pancreas. In: Endocrine physiology. 3rd ed. New York: McGraw Hill; 2010.

    Google Scholar 

  12. Kumar V, Abbas AK, Astor JC. Endocrine system. In: Robbin’s basic pathology. 9th ed. Philadelphia: Elsevier Health Sciences; 2013. p. 716–64.

    Google Scholar 

  13. Mingjun C, Huansheng D, Qingjie P, Hongjun W, Xiao D. Progress in early pancreas development and reprogramming of terminally differentiated cells into β cells. Yi Chuan Hered. 2014;36(6):511–8.

    Google Scholar 

  14. Shanmugasundar G, Bhansali A, Walia R, Dutta P, Upreti V. Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus – a pilot study. Indian J Med Res. 2012;135:78–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Health Quality Ontario. Continuous glucose monitoring for patients with diabetes: an evidence-based analysis. Ont Health Technol Assess Ser. 2011;11(4):1–29.

    Google Scholar 

  16. Thabit H, Hovorka R. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Expert Opin Drug Deliv. 2016;13(3):389–400.

    Article  CAS  PubMed  Google Scholar 

  17. Tomita T. Apoptosis in pancreatic β-islet cells in type 2 diabetes. Bosn J Basic Med Sci. 2016;16(3):162–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Presswala L, Shubrook J. Intensive insulin therapy as the primary treatment for type 2 diabetes. Clin Diabetes. 2011;29(4):151–3.

    Article  Google Scholar 

  19. Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metab Syndr. 2009;1(1):10.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Kumar Pasupulati A, Chitra PS, Reddy GB. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomol Concepts. 2016;7(5–6):293–309.

    CAS  PubMed  Google Scholar 

  21. Nasri H, Rafieian-Kopaei M. Diabetes mellitus and renal failure: prevention and management. J Res Med Sci Off J Isfahan Univ Med Sci. 2015;20(11):1112–20.

    CAS  Google Scholar 

  22. Kontomanolis EN, Panagoutsos S, Pasadakis P, Koukouli Z, Liberis A. Chronic renal failure, diabetes mellitus type-II, and gestation: an overwhelming combination. Clin Exp Obstet Gynecol. 2016;43(2):276–8.

    CAS  PubMed  Google Scholar 

  23. Feldman AZ, Brown FM. Management of type 1 diabetes in pregnancy. Curr Diab Rep. 2016;16(8):76.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Practice Guidelines. ACOG releases guideline on gestational diabetes. Am Fam Physician. 2014;90(6):416–7.

    Google Scholar 

  25. Kimmerle R, Zass RP, Cupisti S, Somville T, Bender R, Pawlowski B, et al. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia. 1995;38(2):227–35.

    Article  CAS  PubMed  Google Scholar 

  26. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996;335(4):226–32.

    Article  CAS  PubMed  Google Scholar 

  27. Purdy LP, Hantsch CE, Molitch ME, Metzger BE, Phelps RL, Dooley SL, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care. 1996;19(10):1067–74.

    Article  CAS  PubMed  Google Scholar 

  28. Helen CCT, Tajunisah I, Reddy SC. Adverse outcomes in Type I diabetic pregnant women with proliferative diabetic retinopathy. Int J Ophthalmol. 2011;4(4):443–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. American Diabetes Association. 13Management of diabetes in pregnancy. Diabetes Care. 2017;40(Suppl 1):S114–9.

    Article  Google Scholar 

  30. Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34(6):1431–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Davies M, Chatterjee S, Khunti K. The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies. Clin Pharmacol Adv Appl. 2016;8:61–81.

    CAS  Google Scholar 

  32. Hendrick van D, Soldin SJ. Advances in clinical chemistry. 1st ed. Vol. 61. San Diego: Academic; 2013. p. 241.

    Google Scholar 

  33. Stockigt JR. Free thyroid hormone measurement. Endocrinol Metab Clin N Am. 2001;30(2):265–89.

    Article  CAS  Google Scholar 

  34. Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):238–49.

    Article  CAS  PubMed  Google Scholar 

  35. Moleti M, Trimarchi F, Vermiglio F. Thyroid physiology in pregnancy. Endocr Pract. 2014;20(6):589–96.

    Article  PubMed  Google Scholar 

  36. Soldin OP, Soldin SJ. Thyroid hormone testing by tandem mass spectrometry. Clin Biochem. 2011;44(1):89–94.

    Article  CAS  PubMed  Google Scholar 

  37. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–65.

    Article  PubMed  CAS  Google Scholar 

  38. Smith TJ, Hegedüs L. Graves’ disease. Longo DL, editor. N Engl J Med. 2016;375(16):1552–65.

    Article  PubMed  Google Scholar 

  39. Chang DLF, Pearce EN. Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. J Thyroid Res. 2013;2013:1–8.

    Article  Google Scholar 

  40. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2016 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid [Internet]. 2017 [cited 2017 Jan 19]. Available from: https://doi.org/10.1089/thy.2016.0457.

    Article  PubMed  Google Scholar 

  41. Manisco G, Potì’ M, Maggiulli G, Di Tullio M, Losappio V, Vernaglione L. Pregnancy in end-stage renal disease patients on dialysis: how to achieve a successful delivery. Clin Kidney J. 2015;8(3):293–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. [Internet]. [Cited 2016 Dec 30]. Available from: https://www.hindawi.com/journals/jtr/2013/851326/abs/.

  43. Goodman WG, Quarles LD. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int. 2008;74(3):276–88.

    Article  CAS  PubMed  Google Scholar 

  44. Bakas P, Chados N, Hassiakos D, Creatsa M, Liapis A, Creasas G. Secondary hypoparathyroidism during pregnancy – a case report and review of the literature. Clin Exp Obstet Gynecol. 2014;42(6):825–6.

    Google Scholar 

  45. Hussain S, Savin V, Piering W, Tomasi J, Blumenthal S. Phosphorus-enriched hemodialysis during pregnancy: two case reports. Hemodial Int. 2005;9(2):147–52.

    Article  PubMed  Google Scholar 

  46. Kirby BJ, Ma Y, Martin HM, Buckle Favaro KL, Karaplis AC, Kovacs CS. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone: PTH DURING PREGNANCY AND LACTATION. J Bone Miner Res. 2013;28(9):1987–2000.

    Article  CAS  PubMed  Google Scholar 

  47. Souberbielle J-C, Cavalier E, Delanaye P, Massart C, Brailly-Tabard S, Cormier C, et al. Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations. Clin Chim Acta. 2015;451:149–53.

    Article  CAS  PubMed  Google Scholar 

  48. Scholl TO, Chen X, Stein TP. Vitamin D, secondary hyperparathyroidism, and preeclampsia. Am J Clin Nutr. 2013;98(3):787–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Podymow T, August P, Akbari A. Management of renal disease in pregnancy. Obstet Gynecol Clin N Am. 2010;37(2):195–210.

    Article  Google Scholar 

  50. Vera L, Oddo S, Di Iorgi N, Bentivoglio G, Giusti M. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature. J Med Case Rep [Internet]. 2016 [cited 2017 Jan 5];10(1):361. Available from: https://doi.org/10.1186/s13256-016-1093-2.

  51. Nadarasa K, Bailey M, Chahal H, Raja O, Bhat R, Gayle C, et al. The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep [Internet]. 2014 [cited 2017 Jan 5]. Available from: https://doi.org/10.1530/EDM-14-0056.

  52. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev. 1997;18(6):832–72.

    CAS  PubMed  Google Scholar 

  53. Balzer MS, Gross MM, Lichtinghagen R, Haller H, Schmitt R. Got milk? Breastfeeding and milk analysis of a mother on chronic hemodialysis. Sands JM, editor. PLoS One. 2015;10(11):e0143340.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Kiernan CM, Solórzano CC. Pheochromocytoma and paraganglioma: diagnosis, genetics, and treatment. Surg Oncol Clin N Am. 2016;25(1):119–38.

    Article  PubMed  Google Scholar 

  55. Wyskida M, Wyskida K, Maruniak-Chudek I, Sikora J, Chudek J. Pheochromocytoma in pregnancy. Postepy Hig Med Dosw Online. 2014;68:749–53.

    Article  PubMed  Google Scholar 

  56. Weingarten M, Rao S, Lincoln K. Successful management of phaeochromocytoma in the third trimester of pregnancy with the use of rapid sequential alpha-adrenergic blockage. Eur J Obstet Gynecol Reprod Biol. 2016;198:174–5.

    Article  PubMed  Google Scholar 

  57. Memon MA, Aziz W, Abbas F. Surgical management of pheochromocytoma in a 13-week pregnant woman. BMJ Case Rep. 2014;2014.

    Google Scholar 

  58. Mohamed Ismail NA, Abd Rahman R, Abd Wahab N, Muhammad R, Nor Azmi K. Pheochromocytoma and pregnancy: a difficult and dangerous ordeal. Malays J Med Sci. 2012;19(1):65–8.

    PubMed  PubMed Central  Google Scholar 

  59. Adenekan A, Faponle A, Badmus T, Sanusi A. Anaesthetic management of giant phaeochromocytoma in a patient with chronic renal disease. J West Afr Coll Surg. 2011;1(2):112–22.

    PubMed  PubMed Central  Google Scholar 

  60. Centers for Disease Control Prevention (CDC). National diabetes statistics report 2014. [Internet]. Centers for Disease Control Prevention; 2014 [Cited 2016 Jun 9]. Available from: http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html.

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Medicine, North Shore University Hospital, Manhasset, NY, USA

    Lubaina Presswala & Alyson K. Myers

  2. Associate Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

    Alyson K. Myers

Authors
  1. Lubaina Presswala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alyson K. Myers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alyson K. Myers .

Editor information

Editors and Affiliations

  1. Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Great Neck, NY, USA

    Mala Sachdeva

  2. Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Great Neck, NY, USA

    Ilene Miller

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Presswala, L., Myers, A.K. (2020). Endocrine Considerations in Pregnant Women with Chronic Kidney Disease. In: Sachdeva, M., Miller, I. (eds) Obstetric and Gynecologic Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-25324-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25324-0_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25323-3

  • Online ISBN: 978-3-030-25324-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation